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Available online 23 February 2008LEI/L-DNase II is the key protein of a caspase-independent pathway activated by serine proteases. LEI
(Leukocyte elastase inhibitor), L-DNase II precursor, is a member of the clade B serpins (also called serpin b1).
In its native conformation it inhibits several intracellular proteases and has an anti-apoptotic activity.
Following a metabolic stress and the increase of protease activity in the cell, LEI is cleaved and transformed
into L-DNase II (LEI-derived DNase II). This transformation is due to a conformational modiﬁcation that
exposes a nuclear localization signal and an endonuclease active site. In this paper we show that LEI can bind
the exportin Crm1, and we identify on LEI a nuclear export signal involved in the control of LEI/L-DNase II
nuclearization in healthy cells. Point mutation of this site increases the accumulation of the molecule in the
nucleus and triggers cell death.
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Serpin1. Introduction
The containment of DNA in the cell nucleus permits the separation
of the genomic information, its transcription and replication, from
protein synthesis and cell metabolism, located in the cytoplasm.
Moreover, nucleo-cytoplasmic compartmentation is important to
regulate the activity of some proteins, like transcription factors [1,2].
While some proteins are small enough to diffuse freely through the
nuclear pore complexes (NPC), many others need to be imported or
exported from the nucleus with a nuclear localization signal (NLS) or
nuclear export signal (NES) respectively. These signals are recognized by
receptor-proteins and carried through the NPC [3]. NLS are classically
recognized by Importin α, while Crm1, also known as Exportin 1, was
foundtobea receptor for variousNES sequences, including viral proteins,
such asHIV-1-Rev [4]. Crm1belongs to the Importin β family (also called
karyopherins). The classical NES consists of a motif containing three or
four leucine-rich hydrophobic residues. During the last few years, these
short leucine-rich NES have been identiﬁed within a variety of proteins
[5]. The export ability of the majority of these proteins is inhibited by
Leptomycin B (LMB), which speciﬁcally binds to Crm1 preventing the
formation of stable NES–Crm1 complexes [6]. This makes LMB a general
inhibitor of a multitude of NES-mediated nuclear pathways.eliers, UMRS 872 Eq. 17, 75006
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l rights reserved.LEI (Leukocyte Elastase Inhibitor), also known as M/NEI (Monocyte/
Neutrophil Elastase Inhibitor) or serpin b1, is a member of the serpin
super-family (serine protease inhibitors). Serpins act as « suicide » or «
single-use » inhibitors: they expose their reactive site loop (RSL) as a
substrate for their target protease.Once theprotease cleaves the loop, the
serpin undergoes an extensive conformational change by the insertion of
the reactive loop inside the molecule, and the protease is trapped in a
covalent complex via a tight-bindingmechanism [7,8]. In living cells, LEI
is located in the cytoplasmwhere it is able to inhibit Elastase, Proteinase
3 and Cathepsin G [9,10].We have shown that, upon apoptosis induction
by etoposide, LEI overexpression could inhibit cell death [11]. However,
other apoptosis inducers shift equilibrium to cleaved LEI, i.e. L-DNase II, a
pro-apoptotic molecule. [11–21]. In a previous study we have detailed
how the cleavage and the subsequent insertion of LEI's reactive loop into
the molecule can unmask two L-DNase II features: an NLS and an
endonuclease active site that permit L-DNase II to translocate into the
nucleus of apoptotic cells and degrade their DNA [22].
We are now trying to unveil the mechanism controlling the switch
between LEI's anti-apoptotic function and L-DNase II pro-death
activity. In the present work we study how LEI/L-DNase II is retained
in the cytoplasm of living cells although its anti-protease function
implies the continuous cleavage of its reactive loop.
In this work we identify a leucine-rich sequence on LEI/L-DNase II
and assess its NES function by site-directed mutagenesis.
2. Materials and methods
2.1. Plasmid puriﬁcation and cell culture
Plasmids were ampliﬁed in DH5α E. coli strain and prepared using QIAprep
Spin Miniprep Kit (QIAgen) for sequencing or using HiSpeed Plasmid Maxi Kit
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modiﬁed Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS),
4 mM glutamine, 200 U/ml penicillin and 0.2 mg/ml streptomycin (all from Gibco®
— Invitrogen) at 37 °C in a humidiﬁed atmosphere containing 5% CO2.
2.2. Immunocytochemistry
Cells were seeded in wells of lab-tek lips (Nunc). After a 1-hour incubation in fresh
medium containing 10 nM Leptomycin B (Merck Biosciences), they were washed twice
with PBS Ca2+–Mg2+, ﬁxed in 4% paraformaldehyde (15 min at room temperature) and
then washed twice with PBS. After permeabilization with Triton X-100 (Sigma-Aldrich)
0.03% (15min), non-speciﬁc protein binding siteswere blockedby incubation in a blockingFig. 1. The putative NES site of LEI. a. Indirect immunoﬂuorescence of LEI shows a cytoplasm
alignment of LEI from different species showing the four amino-acids forming the putative
third and fourth are not conserved in chicken and zebraﬁsh. c. “Space-ﬁlled” 3D representatio
cleavage induces a conformational modiﬁcation that exposes endonuclease active site (not v
Crm1 (Exportin-1). A recombinant his-tagged LEI (LEI) was ﬁxed to a Ni-column that was the
western blot using an anti-Crm1 antibody. A total cell extract was used for a positive control
in parallel (Cal). 25 µg proteins of each fraction were loaded on the SDS-polyacrylamide gelbuffer containing 1% skimmed milk in PBS (1 h, room temperature). Cells were then
incubated with anti-LEI (dilution 1:200) in 0.1% skimmed milk in PBS, 1 h at room
temperature. This was followed by ﬁve washes with 0.1% skimmed milk in PBS and
incubation for 1 h with a 1/100 dilution of an anti-rabbit rhodamine-conjugated. Cells
were ﬁnally washed with PBS, incubated for 5 min with 4–6 di-amindino-2-phenyl
indoledichloride (DAPI, Sigma-Aldrich) and washed twice with PBS. Immunoreactivity was
visualized using ﬂuorescencemicroscopywith anOlympusmicroscope orwith a PCM200.
2.3. Bioinformatics
Proteins were analyzed using RasMol. The Protein Data Base (PDB) code of each
protein was obtained through Medline.ic localization of the protein with a perinuclear concentration. Bar, 10 µm. b. Multiple
NES site. The ﬁrst and second leucines are conserved in all compared species while the
n of uncleaved LEI (left) showing its RSL (green), which is cleaved during apoptosis. This
isible) and NLS (Blue). The putative NES is represented in orange. d. LEI interaction with
n loaded with a Hela cell extract and eluted. The LEI-retained material was analyzed by
(Ctl). As a negative control a Ni-column charged with an His-tagged calmodulin was run
. LEI is able to pull-down Crm1.
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Porcine LEI cDNAwas subcloned into pZeoSV2+ (Invitrogen), into pET23d+ (Novagen)
in framewith the His-tag, and into pDsRed2-C1 plasmid (Clontech) in framewith the red
ﬂuorescent protein fused to its N-term (named pDsRed-LEI), as described previouslyFig. 2. LEI's nuclear export is sensitive to Leptomycin B. a. BHK-21 cells were treated for 1 hwi
DNase II. Control cells exhibit cytoplasmic ﬂuorescence, whereas the ﬂuorescence is strongly
with a pDsRed-LEI chimera. The distribution of this chimera in living cells was followed by
Crm1–NES binding. LMB-treated cells present an abnormal nuclear accumulation of the c
independent assays. Bar, 10 µm.[22]. LEI cDNAwasmutated at speciﬁc bases to convert speciﬁc leucines or valine codons
into alanine codons using Quickchange® II site-directed mutagenesis kit (Stratagene).
Mutagenic primers (L286A: GAG GAG AGC TAC GAC GCC AAC GCC CCG CTG GCA CG,
L290A: TAC GAC CTC AAC GCC CCG GCG GCA CGC CTG, L293A: CTG GCC CCG CTG GCA
CGC GCA GGA GTG CAG GAT CTC TTT GG, V295A: CTG GCA CGC CTG GGA GCA CAG GATth 10 nM Leptomycin B, ﬁxed, and immunostainedwith an antibody raised against LEI/L-
nuclear after the Leptomycin B treatment. Bar, 200 µm. b. BHK-21 cells were transfected
ﬂuorescence microscopy in the presence or in the absence of LMB, an inhibitor of the
himeric protein that increases with time. This experiment is representative of three
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manufacturer's recommandations. The accuracy of the mutations was veriﬁed by
sequencing the entire cDNA using T7 (TAATAC GAC TCA CTATAG GG,MWG-Biotech) and
T7-term (CTA GTT ATT GCT CAG CGG T, MWG-Biotech) primers.Fig. 3. Weight of the different amino-acids in LEI export from the nucleus. a. BHK cells
amino-acids of the putative NES. 24 h after transfection the cells were ﬁxed with 1% PFA
representative of 2 independent experiments. Bar, 10 µm. b. 100 cells per condition were
are represented on this histogram. Wt: wild-type LEI; L286A: punctual mutation transfo
pZeo vector containing the wild-type or a punctually mutated LEI cDNA. 24 h after tran
4 µg of proteins of each fractions were separated by SDS-PAGE. LEI/L-DNase II presenc
cytoplasmic and nuclear fraction purity respectively. d. Using a chemiluminescence mea
signal obtained in the nuclear fraction of each transfection. The histogram shows the mu
wild-type.2.5. Pull-down assay
Recombinant proteins (LEI wt and Calmodulin) were produced in E. coli strain BL21
(DE3) pLysS (Novagen), and pull-down was performed as described previously [22].were transfected with the pDsRed-LEI protein that has been mutagenized on the
, stained with DAPI and visualized by ﬂuorescence microscopy. Chosen pictures are
counted in 2 independent experiments. The percentages of cells having nuclear LEI
rming the leucin on position 286 into alanin. c. BHK cells were transfected with a
sfection, cells were collected and we separated cytoplasmic from nuclear proteins.
e was revealed by western blot. Actin and Lamin B were detected to control the
surement software, we were able to relate the LEI/L-DNase II signal to the Lamin B
tant LEI/L-DNase II accumulation in the nuclei of transfected cells compared to the
Fig. 3 (continued).
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human Exportin-1 antibody (monoclonal clone 17/Exportin-1/CRM1, BD Biosciences).
2.6. Transfection protocol for Leptomycin B treatment and nuclear accumulation estimation
For Leptomycin B experiments, BHK-21 cells were seeded at a density of 5000 cells/
cm2 on glass coverslips in 24-well plates 2 days before transfection. 2 h before
transfection, the culture medium was replaced by fresh medium. The transfection
medium contained 0.4 μg of pDsRed-LEI wild-type and 1 μl of Lipofectamine reagent
(2 mg/ml, Invitrogen) per well. The transfection process occurred at 37 °C for 5 h and
was stopped with DMEM containing 20% FCS. Coverslips were collected 24 h after
transfection, put in fresh medium containing 10 nM Leptomycin B and images were
taken at the indicated times by ﬂuorescence microscopy.
The same method was used to transfect cells with pDsRed-LEI wild-type and
mutants. 24 h after transfection, cells were washed 2 times in cold PBS and ﬁxed 20min
in paraformaldehyde (PFA) 1%. Nuclei were stained with DAPI, embedded on slides in
polyvinyl-alcoholmountingmedium (SIGMA) and coverslipped. For eachmutant, a total
of 200 cells were screened and the presence of ﬂuorescence in their nuclei was
assessed.
2.7. Nuclear/cytoplasmic fractions
The same transfection protocol was used to over-express pZeoLEI wild-type and
mutants in BHK-21 cells. 24 h after transfection, cells were collected by trypsinization,
washed 2 times in cold PBS and resuspended in a ice-cold hypo-osmotic solution of
1.5 mM MgCl2. After mechanical breakage of cell membranes using a tight-ﬁtting
Dounce B potter (10 strokes), they were centrifuged and the cytoplasmic fractions
contained in the supernatants were collected. The pellets werewashed 2 times with the
MgCl2 solution and ﬁnally resuspended in a 10 mM Tris, 60 mM NaCl, 200 mM Sucrose
(pH 7,4) buffer.
LEI presence in the fractions was assessed by western blot using anti-LEI rabbit
antibody. The chemiluminescent reaction was monitored using the Kodak IS2000MM
device, and quantiﬁed with Kodak 1D software. Actin and Lamin B were revealed by
western blot using anti-actin and anti-lamin b antibodies made in goat (I-19 and C-20
respectively, Santa Cruz).
2.8. Survival and cytotoxicity assays
BHK-21 cells were transfected by the Nucleofector® II device (Amaxa) according to
the manufacturer's protocol.
Survival was measured 24 h after transfection by the MTTmethod. Culture medium
was removed, cells were washed in PBS and 250 μl of MTT (1 mg/ml, Sigma-Aldrich)
were added to each well. The plate was kept in a CO2 incubator at 37 °C for 1 h. The cellswere then lysed by the addition of 250 μl of isopropanol. The degree of MTT reduction in
each sample was subsequently assessed by measuring absorption at 570 nM versus
630 nM using a microplate reader (Benchmark Plus, BioRad).
Cytotoxicity was quantiﬁed 24 h after transfection by the measurement of lactate
dehydrogenase (LDH) activity using a colorimetric assay. LDH activity was measured in
each transfection medium in triplicate using the cytotoxicity detection kit (LDH, Bio-
chain), and results were read at 490 nm versus 630 nm with a microplate reader. Cells
treated 24 h with 0.2% Triton X-100 constituted the 100% cytotoxicity control.
3. Results
3.1. Identiﬁcation of a putative leucine-rich NES on LEI/L-DNase II
sequence
In resting BHK cells, which are ﬁbroblasts derived from hamster
kidney, immunocytochemistry experiments showed a cytoplasmic
localization of LEI (Fig. 1a). A similar localizationwas seen in other cell
lines like HeLa, a human cervix carcinoma cell line, or ARPE19 cells, a
lineage of retinal pigmented epithelium (not shown). The LEI labelling
was always seen more concentrated around the nucleus, as it is usally
the case for proteins exhibiting nuclear–cytoplasmic shuttling. As the
NLS was already identiﬁed [22], we looked for a mechanism allowing
nuclear export. By using multiple alignement in serpins of an already
described NES [23], we detected a similar sequence (Fig. 1b), and we
veriﬁed that in cleaved LEI (i.e. L-DNase II) this sequence was exposed
at the surface of the molecule, a mandatory condition for binding
exportin molecules (Fig. 1c).
3.2. Crm1 interacts with LEI/L-DNase II
These bioinformatic data suggested the presence of an accessible
NES site, the sequence of which evoked Crm1 binding. In order to
verify this possiblility we ﬁrst performed pull-down experiments. We
loaded a Ni-Sepharose column charged with an His-tagged recombi-
nant LEI with a HeLa cell extract. After an extensive wash the LEI–
protein complexes were eluted and analysed by western blot (Fig. 1d).
As a negative control, an identical column charged with an His-tagged
Fig. 4. Rate of survival of BHK cells expressing wild-type or mutants LEI. BHK cells were
transfected with a pZeo vector containing the wild-type or a punctually mutated LEI
cDNA. a. 24 h after transfection the rate of survival of the different populations was
measured by the MTT method. Except for L290A, all the mutants display a decrease of
their survival compared to thewild-type. However, this decrease is signiﬁcant for L286A
and V295A only. b. 24 h after transfection the rate of cytotoxicity in the different
transfections was measured by the LDH release method. The mutant V295A exhibits a
signiﬁcant cell death compared to the wild-type. Data are means±standard deviations.
⁎Pb0.05; ⁎⁎⁎Pb0.001 (Chi-square test vs. LEI wt).
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positive control. As it is shown on Fig. 1d, while the LEI-charged
columnpulled down Crm1, the calmodulin column did not, suggesting
the presence of a Crm1 binding site in LEI.
3.3. LEI/L-DNase II nuclear export is Leptomycin B sensitive
In order to see if this binding had a functional signiﬁcance we
treated BHK-21 cells with Leptomycin B (LMB), a very well known
inhibitor of Crm1. LEI was immuno-detected. Fig. 2a shows cells in the
presence or in the absence of LMB. We also performed an LMB
treatment on cells over-expressing a LEI–DsRed chimera, allowing its
detection in living cells by ﬂuorescencemicroscopy. During the time of
the experiment, untreated cells did not show any change in
ﬂuorescence distribution while in LMB-treated cells a progressive
accumulation of the chimeric protein was seen in the nucleus.
These results indicated that there was a constitutive nuclear export
of LEI in resting cells, implying a shuttling of LEI as suspected.
Secondly, it also suggested that this export is mediated by Crm1
receptor.
3.4. Functional characterization of the NES by site-directed mutagenesis
We next investigated whether the in silico identiﬁed sequence was
responsible for this nuclear extrusion. To do this we performed site-
directed mutagenesis of all the hydrophobic residues of the putative
NES. Results are shown on Fig. 3. Fig. 3a shows representative ﬁelds of
3 mutants compared to the wild-type. White arrows indicate cells
with abnormal concentration of LEI in the nucleus. This effect was
quantitatively evaluated by counting the cells displaying a nuclear
localization of the ﬂuorescence and comparing them to cells
transfected with a wild-type LEI chimera (Fig. 3b). Cells transfected
with wild-type LEI showed only a few cells with a nuclear
ﬂuorescence. This ﬂuorescence increases when leucine 290 is
transformed into alanine and is dramatically increased if either
leucine 293 or valine 295 are mutated. It is also of interest to note that
many round and ﬂoating cells were observable in V295A mutant
transfected cells, thus indicating cell death. As no ﬂuorescence could
be seen, the rate of nuclearization of L286A could not be determined.
We also separated the cytoplasmic and nuclear fractions of cells
over-expressing wild-type or mutant LEI (non-fused with DsRed), and
looked for the presence of LEI by western blot (Fig. 3c). Fig. 3d shows a
quantiﬁcation of LEI in the nuclear fraction related to Lamin B quantity
using the chemoluminescence acquisition software. These results
conﬁrmed the immunoﬂuorescence study that indicated that valine
295 is a critical residue for LEI nucleo-cytoplasmic trafﬁcking.
However this methodwas not able to detect any nuclear accumulation
of leucines 293 or 290 mutants compared to the wild-type.
3.5. Overexpression of mutant LEI/L-DNase II decreases cell survival
The nuclear translocation of LEI depends on the cleavage of its RSL
that allows the NLS exposure. This cleavage also exposes an
endonuclease active site. As the increase of the amount of L-DNase
II in the nucleus leads to cell death [22] we investigated whether the
cells over-expressing NES-mutated LEI had a weaker survival. Results
are shown on Fig. 4, where the rates of survival of cells after
transfection with the different mutated proteins are compared to
control cells (cells transfected with thewild-type protein). All the cells
expressing mutated proteins show a decrease of their survival, as
measured by the MTT assay (Fig. 4a). A LDH release cytotoxicity assay
indicates that this decrease is due to cell death (Fig. 4b). DNA content
quantiﬁcation by ﬂow-cytometry reveals no variation in cell pro-
liferation between the different transfection experiments (not
shown), and the expression levels of the transfected wild-type LEI
and the different mutants were similar (Supplemental Figure).The rate of cell death is very important for V295A, the mutant that
had also the most important rate of cells with nuclear retention of LEI,
suggesting that valine 295 is critical for LEI/L-DNase II export.
4. Discussion
In many stress conditions [11–21] the cleavage of LEI leads to its
transformation into L-DNase II that triggers apoptosis in the cell [22].
As the same cleavage is involved in the anti-protease function of the
molecule, a base line of production of L-DNase II is unavoidable in
healthy cells. One means of controlling this inconvenience is to either
interfere with nuclear translocation of L-DNase II or to extrude the
produced endonuclease from the nucleus. One sequence involved in
nuclear extrusion is the nuclear export signal (NES), consisting of a
motif containing three or four hydrophobic residues, which is
responsible for transporting proteins out of the nucleus [24]. NES-
dependent nuclear export is mediated by the soluble export carrier
Crm1/exportin. Crm1 is regulated by a small Ras-like GTPase, RanGTP,
which is required for the directionality of the protein transport. Crm1
recognizes the NES, leading to the formation of trimeric NES/Crm1/
RanGTP complexes. These complexes are then shuttled from the
nucleoplasm to the cytoplasm via interactions with nuclear pore
proteins, such as the nucleoporin CAN/Nup214 [25].
In this work we have found a consensus NES sequence in LEI that
binds Crm1, as this receptor is pulled down by an LEI afﬁnity column;
we also observed that the treatment of the cells with LMB induces LEI
accumulation in the nucleus, thus indicating that LEI undergoes a
nucleo-cytoplasmic shuttling in healthy cells. In addition, site-
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reduces nuclear export of LEI if compared with the wild-type
molecule. Taken together these results indicate that the nuclear–
cytoplasmic trafﬁc of LEI/L-DNase II depends not only on the presence
of a NLS as we have previously shown but also of a NES that ensures
the export of the molecule in healthy cells.
The nuclear extrusion of LEI/L-DNase II in healthy cells seems to be
a very important function as the overexpresion of NES-mutated LEI
induces cell death. This feature is in agreement with our previous
results indicating that the pro-apoptotic effect of L-DNase II depends
on its nuclear translocation [22]. Indeed, we have shown that the
overexpression of an NLS-mutated LEI failed to nuclearize and to
diminish cell survival in HMA-induced cell death compared to the
wild-type. Thus, the results presented here conﬁrm that LEI/L-DNase II
subcellular localization is determinant for its pro-apoptotic activity.
This points out the existence of mechanisms that may be able to
regulate the dominance of the NLS on the NES (and vice versa) to drive
LEI/L-DNase II subcellular localization, depending on the cellular
context. One of these is certainly the steric hindrance of LEI reactive
loop that blocks the access of Importin α to the NLS, and needs to be
cleaved to transform LEI in L-DNase II.
The binding of the NES to Crm1 depends not only on its sequence
but also on the exposure of the sequence at the surface of the
molecule. We have analyzed the position of this sequence in LEI and
we have found that it is exposed in both LEI and L-DNase II forms of
the molecule. This NES consensus sequence was already described in
other serpins of the clade B. Rodriguez et al. show that it is functionally
active for CrmA (a serpin from cowpox virus) and PI-9 (serpin b9),
Alpha-1 Antitrypsin (serpin a1) and Maspin (serpin b5) [23]. As for LEI
the sequence is exposed at the surface of the molecule (in silico
studies, not shown) and might be functionnal. Alternatively, as LEI is
phylogenetically one of the oldest proteins of clade B serpins [26,27],
the NES of the other proteins might be an evolutionary remnant.
Moreover, this sequence could be important for the folding of these
metastable proteins.
In addition, our results indicate that the external residues of the
NES seem to be more important than the central ones. We also see a
good correlation beetween the survival rates and the ﬂuorescence
accumulated in the nucleus, although this is less clear in the
western blotting experiments probably because we pool all the cells
and only a fraction of them suffer nuclear translocation. Moreover,
as these cells are prone to apoptosis and secondary necrosis we
probably lost many of them during the extraction procedure, so
that, only the mutant presenting the most dramatic impairment in
nuclear extrussion gives signiﬁcant differences. Actually, this
correlation could not be seen for L286A, probably because of a
misfolding of the ﬂuorescent chimeric protein causing its precipita-
tion. LEI L293A mutant exhibited a relatively high percentage of
transfected cells with ﬂuorescent nuclei, but we were not able to
detect this enhanced nuclearization by western blotting after
nucleo-cytoplasmic fractionation. In addition, the cell death
induced by its overexpression was moderated, thus indicating
that this leucin may not be the most indispensable residue for the
NES function. However, both ﬂuorescent, western blotting and
survival data indicate that the most important amino-acid is the
most C-terminal, val 295, and this is in agreement with previous
studies [28]. This amino-acid is conserved in higher species but is
replaced by leucine or methionine – which are also hydrophobic
amino-acids – in lower species (chicken and zebraﬁsh). This may be
considered as a conservative mutation since CrmA presents a
leucine in this position and MENT, an heterochromatin-associated
serpin, a methionine [23].
Several serpins of the clade B display NLS and NES but their
function in the nucleus is not very well established. LEI/L-DNase II,
however, has a cytoplasmic and a nuclear form that bear very distinct
activities and functions. In this molecule the presence of a NLS ismandatory for its pro-apoptotic activity. In this study we show that
the cytoplasmic localization of the protein is also controlled by a NES
that extrudes the protein when nuclearized in healthy cells. Inhibition
of this NES triggers apoptosis. This ﬁnding indicates that several levels
of regulation operate on this apoptotic system.
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